In acute bacterial meningitis for patients younger than 1 month, which empiric regimen is appropriate?

In acute bacterial meningitis for patients younger than 1 month, which empiric regimen is appropriate?

• A. Acyclovir.
• B. Azithromycin.
• C. Ceftriaxone monotherapy.
• D. Ampicillin plus Cefotaxime.

Answer: (D)

In infants younger than one month, the pathogens that commonly cause meningitis include Listeria monocytogenes, group B Streptococcus, and gram-negative organisms like E. coli. The empiric choice must cover both Listeria and these neonatal pathogens. Ampicillin provides good coverage for Listeria and GBS, while cefotaxime offers strong CSF penetration and covers many gram-negative bacteria such as E. coli. This combination addresses the key risks in this age group. Ceftriaxone monotherapy is not ideal here because it does not cover Listeria and is avoided in neonates due to risk of kernicterus from bilirubin displacement. Acyclovir targets viral encephalitis (e.g., HSV) rather than bacterial meningitis, so it’s not appropriate as empiric therapy for bacterial meningitis. Azithromycin also does not provide reliable coverage for the common neonatal meningitis pathogens and isn’t used empirically in this scenario. Thus, the best empiric regimen for a patient under one month with suspected bacterial meningitis is ampicillin plus cefotaxime.

In infants younger than one month, the pathogens that commonly cause meningitis include Listeria monocytogenes, group B Streptococcus, and gram-negative organisms like E. coli. The empiric choice must cover both Listeria and these neonatal pathogens. Ampicillin provides good coverage for Listeria and GBS, while cefotaxime offers strong CSF penetration and covers many gram-negative bacteria such as E. coli. This combination addresses the key risks in this age group.

Ceftriaxone monotherapy is not ideal here because it does not cover Listeria and is avoided in neonates due to risk of kernicterus from bilirubin displacement. Acyclovir targets viral encephalitis (e.g., HSV) rather than bacterial meningitis, so it’s not appropriate as empiric therapy for bacterial meningitis. Azithromycin also does not provide reliable coverage for the common neonatal meningitis pathogens and isn’t used empirically in this scenario.

Thus, the best empiric regimen for a patient under one month with suspected bacterial meningitis is ampicillin plus cefotaxime.